Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_assertion description "[The present results indicated that LY294002 inhibits the malignant phenotype of OS cells via modulation of the PI3K/Akt/FASN signaling pathway in vitro and may be a new therapeutic strategy for the management of OS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_assertion evidence source_evidence_literature NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_assertion SIO_000772 25351625 NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_assertion wasDerivedFrom befree-2016 NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_assertion wasGeneratedBy ECO_0000203 NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1233250.RAKXuTn3rlvH0_7kyIaLDCM1BTbgRN-BVUi57v0BKjSdI130_provenance.